Compile Data Set for Download or QSAR
maximum 50k data
Found 181 Enz. Inhib. hit(s) with all data for entry = 7023
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166798(US9073870, 94)
Affinity DataIC50:  36nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166912(US9073870, 208)
Affinity DataIC50:  40nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166805(US9073870, 101)
Affinity DataIC50:  59nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166744(US9073870, 40)
Affinity DataIC50:  61nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166790(US9073870, 86)
Affinity DataIC50:  67nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166908(US9073870, 204)
Affinity DataIC50:  69nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166820(US9073870, 116)
Affinity DataIC50:  70nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166909(US9073870, 205)
Affinity DataIC50:  74nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166799(US9073870, 95)
Affinity DataIC50:  75nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166881(US9073870, 177)
Affinity DataIC50:  76nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166868(US9073870, 164)
Affinity DataIC50:  77nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166904(US9073870, 200)
Affinity DataIC50:  83nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166725(US9073870, 21)
Affinity DataIC50:  86nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166910(US9073870, 206)
Affinity DataIC50:  86nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166850(US9073870, 146)
Affinity DataIC50:  87nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166853(US9073870, 149)
Affinity DataIC50:  91nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166856(US9073870, 152)
Affinity DataIC50:  94nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166903(US9073870, 199)
Affinity DataIC50:  96nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166755(US9073870, 51)
Affinity DataIC50:  101nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166844(US9073870, 140)
Affinity DataIC50:  101nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166751(US9073870, 47)
Affinity DataIC50:  106nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166742(US9073870, 38)
Affinity DataIC50:  106nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166719(US9073870, 15)
Affinity DataIC50:  109nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166728(US9073870, 24)
Affinity DataIC50:  120nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166845(US9073870, 141)
Affinity DataIC50:  133nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166862(US9073870, 158)
Affinity DataIC50:  135nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166718(US9073870, 14)
Affinity DataIC50:  136nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166724(US9073870, 20)
Affinity DataIC50:  138nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166822(US9073870, 118)
Affinity DataIC50:  149nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166905(US9073870, 201)
Affinity DataIC50:  149nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166708(US9073870, 4)
Affinity DataIC50:  156nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166793(US9073870, 89)
Affinity DataIC50:  164nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166746(US9073870, 42)
Affinity DataIC50:  165nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166861(US9073870, 157)
Affinity DataIC50:  168nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166748(US9073870, 44)
Affinity DataIC50:  175nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166879(US9073870, 175)
Affinity DataIC50:  176nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166878(US9073870, 174)
Affinity DataIC50:  178nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166847(US9073870, 143)
Affinity DataIC50:  179nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166864(US9073870, 160)
Affinity DataIC50:  182nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166858(US9073870, 154)
Affinity DataIC50:  185nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166727(US9073870, 23)
Affinity DataIC50:  186nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166753(US9073870, 49)
Affinity DataIC50:  186nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166741(US9073870, 37)
Affinity DataIC50:  197nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166860(US9073870, 156)
Affinity DataIC50:  198nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166888(US9073870, 184)
Affinity DataIC50:  202nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166883(US9073870, 179)
Affinity DataIC50:  205nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166836(US9073870, 132)
Affinity DataIC50:  210nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166819(US9073870, 115)
Affinity DataIC50:  214nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166812(US9073870, 108)
Affinity DataIC50:  221nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Target11-beta-hydroxysteroid dehydrogenase 1(Homo sapiens (Human))
Boehringer Ingelheim International

US Patent
LigandPNGBDBM166852(US9073870, 148)
Affinity DataIC50:  230nMpH: 6.0 T: 2°CAssay Description:In vitro inhibition of 11beta -HSD1 by test compounds was determined with HTRF (Homogeneous Time-Resolved Fluorescence) technology (cisbio internatio...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 181 total ) | Next | Last >>
Jump to: